Johnson & Johnson (NYSE:JNJ)
Stock Price:
$0.00
+
(%)
Updated
Nov 29, 2023 05:12 AM GMT+0000
| Market Cap | 0 |
|---|---|
| Revenue | 95.33B |
| Gross Profit | 64.36B |
| Shares Out | 2.41B |
| EPS (ttm) | 13.26 |
| PE Ratio | 10.2377 |
| Forward PE | 14.0060 |
| Dividend Rate (ttm) | 4.5904 |
| Dividend Yield | 0.0312 |
| Trading Day | Nov 29 |
|---|---|
| Last Price | $0.00 |
| Previous Close | $0.00 |
| Change ($) | |
| Change (%) | % |
| Day's Open | $Market Closed |
| Day's Range | $ + $0 |
| Day's Volume | 0 |
| 52 Week Range | $N.A - $N.A |
About Johnson & Johnson
NYSE:JNJ stock is currently trading at $0.00 as of 12:00 AM UTC, Jan 1, 1970. Use the financials tab to find out more about Johnson & Johnson's key financial metrics and recent earnings reports, or track its share price in real time on the chart tab. If you would like to buy shares in Johnson & Johnson, our detailed guide explains how to buy Johnson & Johnson stock.
News
Quick info
Country
United States
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
152,700
CEO
Alex Gorsky
Address
1 Johnson And Johnson Plz
New Brunswick
New Jersey
08933-0001
New Brunswick
New Jersey
08933-0001
Phone
17325242455
Website
https://www.jnj.com/
Ticker Symbol
JNJ
Reporting Currency
USD
Johnson & Johnson income statements (2023)
| October 2023 | July 2023 | April 2023 | |
|---|---|---|---|
| Total Revenue | 21.35B | 25.53B | 24.75B |
| Cost of Revenue | 6.61B | 8.21B | 8.40B |
| Gross Profit | 14.75B | 17.32B | 16.35B |
| Research & Development | 3.45B | 3.83B | 3.56B |
| Selling General & Admin | 5.40B | 6.67B | 6.14B |
| Operating Expense | N.A | N.A | N.A |
| Operating Income | 5.90B | 6.82B | 6.65B |
| Other Income Expense Net | 0 | 0 | 0 |
| EBIT | 5.90B | 6.82B | 6.65B |
| Interest Income | 0 | 0 | 0 |
| Pretax Income | 5.22B | 6.76B | 0 |
| Income Tax | 0.91B | 1.62B | 0 |
| Minority Interest | 0 | 0 | 0 |
| Net Income | 26.03B | 5.14B | 0 |
| Net Income Basic | 26.03B | 5.14B | 0 |
Johnson & Johnson income statements (2022)
| February 2023 | October 2022 | July 2022 | |
|---|---|---|---|
| Total Revenue | 23.71B | 23.79B | 24.02B |
| Cost of Revenue | 7.77B | 7.81B | 7.92B |
| Gross Profit | 15.94B | 15.98B | 16.10B |
| Research & Development | 3.84B | 3.60B | 3.70B |
| Selling General & Admin | 6.51B | 6.09B | 6.23B |
| Operating Expense | N.A | N.A | N.A |
| Operating Income | 5.59B | 6.30B | 6.17B |
| Other Income Expense Net | 0 | 0 | 0 |
| EBIT | 5.59B | 6.30B | 6.17B |
| Interest Income | 0 | 0 | 0 |
| Pretax Income | 4.20B | 5.82B | 5.84B |
| Income Tax | 681M | 1.36B | 1.03B |
| Minority Interest | 0 | 0 | 0 |
| Net Income | 3.52B | 4.46B | 4.81B |
| Net Income Basic | 3.52B | 4.46B | 4.81B |
Johnson & Johnson balance sheet (2023)
| October 2023 | July 2023 | April 2023 | February 2023 | |
|---|---|---|---|---|
| Current Cash | 23.51B | 28.51B | 24.61B | 23.52B |
| Receivables | 14.80B | 16.78B | 16.35B | 16.16B |
| Inventory | 11.20B | 12.89B | 12.81B | 12.48B |
| Current Assets | 53.70B | 60.57B | 64.39B | 55.29B |
| Other Current Assets | 4.20B | 2.40B | 2.92B | 3.13B |
| Short Term Investments | 4.20B | 2.40B | 2.92B | 3.13B |
| Long Term Investments | 112.36B | 131.12B | 131.58B | 132.08B |
| Property/Plant Equipment | 18.82B | 20.58B | 20.17B | 19.80B |
| Good Will | 36.12B | 45.44B | 45.58B | 45.23B |
| Intangible Assets | 35.02B | 46.25B | 47.45B | 48.33B |
| Tangible Assets (Net) | 83M | 0 | 0 | 0 |
| Other Assets | 13.13B | 10.08B | 9.57B | 9.03B |
| Total Assets | 166.06B | 191.69B | 195.97B | 187.38B |
| Accounts Payable | 8.36B | 10.44B | 9.91B | 11.70B |
| Other Current Liabilities | 32.15B | 32.03B | 32.49B | 31.33B |
| Total Current Liabilities | 44.37B | 54.17B | 60.37B | 55.80B |
| Total Liabilities | 94.83B | 116.54B | 125.10B | 110.57B |
| Long Term Debt | 26.05B | 33.90B | 34.93B | 26.89B |
| Current Long Term Debt | 3.87B | 11.70B | 17.98B | 12.77B |
| Minority Interest | 0 | 1.26B | 0 | 0 |
| Common Stock | 2.52B | 2.60B | 2.61B | 2.61B |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | 152.54B | 129.38B | 124.56B | 128.35B |
| Capital Surplus | N.A | N.A | N.A | N.A |
| Shareholder Equity | 71.23B | 75.15B | 70.87B | 76.80B |
| Other Liabilities | 21.79B | 23.58B | 25.38B | 21.51B |
Johnson & Johnson balance sheet (2022)
| October 2022 | July 2022 | |
|---|---|---|
| Current Cash | 34.08B | 32.57B |
| Receivables | 15.89B | 16.14B |
| Inventory | 11.68B | 11.44B |
| Current Assets | 65.24B | 63.85B |
| Other Current Assets | 3.59B | 3.70B |
| Short Term Investments | 3.59B | 3.70B |
| Long Term Investments | 109.89B | 113.88B |
| Property/Plant Equipment | 18.15B | 18.35B |
| Good Will | 33.38B | 34.17B |
| Intangible Assets | 40.34B | 42.41B |
| Tangible Assets (Net) | 880M | 0 |
| Other Assets | 8.63B | 9.44B |
| Total Assets | 175.12B | 177.72B |
| Accounts Payable | 10.15B | 9.77B |
| Other Current Liabilities | 30.97B | 30.75B |
| Total Current Liabilities | 45.54B | 44.82B |
| Total Liabilities | 100.53B | 101.37B |
| Long Term Debt | 27.60B | 28.29B |
| Current Long Term Debt | 4.42B | 4.31B |
| Minority Interest | 0 | 0 |
| Common Stock | 2.63B | 2.63B |
| Treasury Stock | 0 | 0 |
| Retained Earnings | 127.92B | 126.22B |
| Capital Surplus | N.A | N.A |
| Shareholder Equity | 74.60B | 76.36B |
| Other Liabilities | 22.43B | 23.24B |
Johnson & Johnson cash flow (2023)
| October 2023 | July 2023 | April 2023 | February 2023 | October 2022 | July 2022 | |
|---|---|---|---|---|---|---|
| Net Income | 26.03B | 5.14B | 0 | 3.52B | 4.46B | 4.81B |
| Depreciation | 1.83B | 1.93B | 1.88B | 1.77B | 1.69B | 1.74B |
| Changes in Receivables | 14.80B | 16.78B | 16.35B | 16.16B | 15.89B | 16.14B |
| Changes in Inventories | 11.20B | 12.89B | 12.81B | 12.48B | 11.68B | 11.44B |
| Cash Change | 23.51B | 28.51B | 24.61B | 23.52B | 34.08B | 32.57B |
| Cash Flow | 7.49B | 4.18B | 3.26B | 5.35B | 6.28B | 5.58B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | N.A | N.A | N.A | N.A | N.A | N.A |
| Investing Activity (other) | N.A | N.A | N.A | N.A | N.A | N.A |
| Total Investing Cash Flows | 2.54B | 0 | 3.32B | 0 | 0 | 0 |
| Dividends Paid | N.A | N.A | N.A | N.A | N.A | N.A |
| Net Borrowings | 2.21B | 14.70B | 25.37B | 13.01B | 0 | 0 |
| Other Financing Cash Flows | N.A | N.A | N.A | N.A | N.A | N.A |
| Cash Flow Financing | 0 | 0 | 6.14B | 1.70B | 0 | 0 |
| Exchange Rate Effect | N.A | N.A | N.A | N.A | N.A | N.A |
Johnson & Johnson dividends
| Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
|---|---|---|---|---|---|---|
| 20-11-2023 | 05-12-2023 | 21-11-2023 | 19-10-2023 | 1.19 | Ordinary Shares | Quarterly |
| 25-08-2023 | 07-09-2023 | 28-08-2023 | 20-07-2023 | 1.19 | Ordinary Shares | Quarterly |
| 22-05-2023 | 06-06-2023 | 23-05-2023 | 18-04-2023 | 1.19 | Ordinary Shares | Quarterly |
| 17-02-2023 | 07-03-2023 | 21-02-2023 | 03-01-2023 | 1.13 | Ordinary Shares | Quarterly |
| 21-11-2022 | 06-12-2022 | 22-11-2022 | 19-10-2022 | 1.13 | Ordinary Shares | Quarterly |
| 22-08-2022 | 06-09-2022 | 23-08-2022 | 18-07-2022 | 1.13 | Ordinary Shares | Quarterly |
Total Valuation
has a market cap or net worth of $0. The enterprise value is $360.88 billion.
Market Cap
0
Enterprise Value
360.88B
Important Dates
Earnings Date
Jan 23, 2024
Ex-Dividend Date
n.a
Share Statistics
has 2.41 billion shares outstanding.
Shares Outstanding
2.41B
Valuation Ratios
The trailing PE ratio is 10.2377 and the forward PE ratio is 14.0060. 's PEG ratio is 0.1208.
PE Ratio
10.2377
Forward PE
14.0060
PS Ratio
3.7200
PB Ratio
4.9800
PEG Ratio
0.1208
Stock Price Statistics
The stock price has increased by -0.1050%. The beta is 0.0000, so 's price volatility has been lower than the market average.
Beta (1Y)
0.0000
52-Week Price Change
-0.1050%
50-Day Moving Average
153.00
200-Day Moving Average
160.00
Average Volume (30 Days)
7.02M
Income Statement
In the last 12 months, had revenue of $95.33 billion and earned $64.36 billion in profits. Earnings per share was $13.26.
Revenue
95.33B
Gross Profit
64.36B
EBITDA
32.38B
Earnings per Share
13.26
About
Country
United States
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
152,700
CEO
Alex Gorsky
Address
1 Johnson And Johnson Plz
New Brunswick
New Jersey
08933-0001
New Brunswick
New Jersey
08933-0001
Phone
17325242455
Website
https://www.jnj.com/
Ticker Symbol
JNJ
Reporting Currency
USD
Key Executives
Mccoy Sherilyn S
Member, Executive Committee
Fasolo Peter
VP, Global Human Resources
Kapusta Ronald A
Controller, CAO
Broadhurst Vanessa
EVP, Global Corp Aff.
Pruden Gary J
Exec VP, WW Chair, Med Devices
Duato Joaquin
Vice Chair, Exec Committee
Peterson Sandra E
Group Worldwide Chairman
Mesquita Jorge S.
Exec VP, WW Chair, Consumer
Weldon William C
Chairman/CEO
Valeriani Nicholas J
VP, Strategy & Growth
Caruso Dominic J
Chief Financial Officer
Poon Christine A
Vice Chairman
Hait William
haitpoa1.txt
Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer
Mammen Mathai
EVP, Pharm, R&D
Foster-cheek Kaye I
VP, Human Resources
Goggins Colleen A
Member, Executive Committee
Gorsky Alex
Member, Executive Committee